Cite

HARVARD Citation

    Dong, Z. et al. (2017). EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer. Oncoimmunology. p. . [Online]. 
  
Back to record